Quick Facts
- Primary Cause: Reactivation of the latent varicella-zoster virus (VZV) following a previous chickenpox infection.
- Risk Window: The likelihood of reactivation increases significantly after age 50 as immune function naturally declines.
- Key Mechanism: A failure of cell-mediated immunity, specifically the T-cell response, allowing the virus to escape its dormant state.
- Prevalence: Approximately 1 out of every 3 people in the United States will develop shingles during their lifetime.
- Annual Impact: There are an estimated 1 million cases of shingles occurring each year in the U.S.
- Prevention: The recombinant zoster vaccine is over 90 percent effective at preventing shingles and its complications.
The varicella-zoster virus (VZV) causes shingles by reactivating after years of dormancy in the sensory nerve cells of the dorsal root ganglia. Reactivation typically occurs when the immune system weakens due to aging or stress, which is the primary driver for what causes the chickenpox virus to reactivate as shingles in older adults.
The Silent Resident: How VZV Enters a Latent State
To understand why shingles occurs, we must first look back at the initial encounter with the virus. When a person contracts chickenpox, usually during childhood, the varicella-zoster virus causes a widespread, itchy rash. While the immune system eventually clears the skin lesions, it does not completely eliminate the virus from the body. Instead, the virus employs a clever survival strategy known as viral latency.
During the tail end of the primary infection, the virus travels from the skin lesions along the sensory neurons to the nerve cell bodies. It eventually settles in the dorsal root ganglia, which are clusters of nerve cell bodies located along the spinal cord. Here, the virus enters a dormant state, where its DNA exists as a circular episome within the nucleus of the ganglionic neurons.
The varicella-zoster virus dormancy mechanism is a complex biological stalemate. For decades, the virus remains "caged" within these nerve cells. It produces only a few specific proteins that help it hide from the immune system while preventing its own replication. Scientists often refer to this as a cytoplasmic cage, where viral proteins are sequestered in the cytoplasm of the neuron to prevent them from entering the nucleus and triggering the lytic phase, which is the active state of viral replication. As long as the body maintains strong cell-mediated immunity, specifically through a robust T-cell response, the virus stays in check. This explains why chickenpox virus stays dormant in nerve cells for the majority of a person’s life without causing any symptoms.
The Awakening: Biological Triggers for Reactivation
The transition from a dormant resident to an active pathogen is not a random event; it is usually triggered by a decline in immune surveillance. The most common factor is immunosenescence, which is the natural, age-related decline of the immune system. This explains why about half of all shingles cases occur in adults aged 60 years or older. As we age, our T-cells become less efficient at recognizing and suppressing the latent virus.
When the immune system's grip loosens, the virus begins to replicate within the nerve cell. It then travels back down the sensory neurons to the skin. Because each group of nerves serves a specific area of the body, the resulting rash appears in a localized band known as a dermatome distribution. This is why shingles usually appears on only one side of the body or face.
Beyond natural aging, other factors can significantly influence the impact of immune system health on shingles risk. Severe psychological stress is a well-documented trigger. When the body is under high stress, it releases hormones like cortisol that can suppress cell-mediated immunity. This creates a window of opportunity for the virus to "wake up." Many patients report experiencing a major life stressor—such as a bereavement or a high-pressure career event—just weeks before their shingles rash appeared. This leads many to ask: can stress trigger shingles virus reactivation? The clinical consensus is a resounding yes, as stress effectively lowers the biological barriers that maintain viral latency.
Early signs chickenpox virus is reactivating often include a tingling, itching, or "burning" sensation in a specific area of the skin, even before a visible rash appears. This prodromal phase occurs as the virus travels through the nerve, causing inflammation and irritation along the way.
Risk Factors Beyond Aging: Genetics and Environment
While age is the most significant factor, it is not the only one. Research into genetic susceptibility has identified specific markers, such as the ATA and GCC haplotypes, which may make certain individuals more prone to reactivation. These genetic variations influence how the immune system interacts with the varicella-zoster virus, potentially explaining why some people develop shingles multiple times while others never do.
Interestingly, environmental factors and geographical location also play a role. In temperate climates, chickenpox is often a childhood rite of passage, meaning more than 99 percent of Americans born before 1980 have had the virus and are therefore at risk for the virus reactivating as shingles later in life. In tropical climates, the primary infection often occurs later in life, which shifts the shingles risk factors for seniors and older adults in those regions.
Gender is another factor that researchers are closely monitoring. Statistically, women tend to have higher rates of shingles than men, though the biological reasons for this are still being investigated. It is hypothesized that hormonal fluctuations throughout life may impact the stability of the T-cell response that keeps the virus dormant.
Prevention and Early Intervention Protocols
Given that the virus is already present in nearly every adult over a certain age, prevention focuses on boosting the immune system's ability to maintain latency. The most effective tool we have is the recombinant zoster vaccine. Unlike older versions of the vaccine, the recombinant version does not use a live virus. Instead, it uses a specific component of the virus combined with an adjuvant to "remind" the immune system how to fight VZV.
The process of preventing VZV reactivation through vaccination is highly successful, with the current vaccine showing over 90% efficacy in clinical trials. By strengthening the T-cell response, the vaccine helps ensure the virus remains in its dormant state, even as immunosenescence begins to take hold. For those who are already at a higher risk, preventing shingles with the recombinant zoster vaccine is the gold standard for avoiding not just the rash, but the debilitating complication known as postherpetic neuralgia—a chronic nerve pain that can last for months or years after the rash has healed.
For individuals who have been exposed to the virus and are at high risk for severe disease, there is a critical 96-hour window for administering Varicella-Zoster Immune Globulin (VarIg). This can help provide immediate, passive immunity to prevent the virus from taking hold or reactivating. Additionally, managing viral shedding is important for those with an active shingles rash; while you cannot "catch" shingles from someone else, you can spread the virus to someone who has never had chickenpox, potentially causing a primary infection in them.

Comparison: Latent Phase vs. Lytic Phase
| Feature | Latent Phase (Dormant) | Lytic Phase (Active Shingles) |
|---|---|---|
| Location | Nucleus of ganglionic neurons | Sensory neurons and skin cells |
| Viral Activity | Minimal; DNA is circular (episome) | Rapid replication and travel |
| Symptoms | None | Pain, tingling, and localized rash |
| Immune Status | Strong T-cell suppression | Weakened cell-mediated immunity |
| Transmission | None | High (via viral shedding from lesions) |
FAQ
Why does chicken pox come back as shingles?
The virus never actually leaves your body after the initial infection. It retreats to nerve tissues near your spinal cord and brain. When your immune system's ability to suppress the virus weakens—due to age, illness, or stress—the virus reactivates and travels down the nerve fibers to the skin, causing the painful shingles rash.
What causes the shingles virus to wake up?
The primary trigger is a decline in cell-mediated immunity. This is often caused by the natural aging process, known as immunosenescence. Other triggers include high levels of psychological stress, the use of immunosuppressive medications (like chemotherapy or steroids), or underlying health conditions that tax the immune system.
Is shingles from poor hygiene?
No, shingles has nothing to do with hygiene. It is a biological event caused by the reactivation of a virus that is already inside your body. You cannot "catch" shingles from the environment or from lack of cleanliness; it is entirely dependent on the relationship between your immune system and the latent varicella-zoster virus.
What do you get later in life if you had chicken pox?
If you had chicken pox earlier in life, the varicella-zoster virus remains in your body. This puts you at risk for developing shingles (herpes zoster) later in life. You may also be at risk for related complications like postherpetic neuralgia or, in rare cases, zoster sine herpete, which is shingles pain without the characteristic rash.
What vitamin are you lacking with shingles?
While shingles is caused by a virus and not a vitamin deficiency, some research suggests that low levels of Vitamin D and Vitamin B12 may be associated with a higher risk of reactivation or increased severity of postherpetic neuralgia. Maintaining a balanced intake of vitamins supports overall immune health, but supplements should always be discussed with a doctor as part of a broader prevention strategy.
Maintaining a healthy lifestyle and staying up to date with vaccinations are the best ways to keep the "silent resident" dormant. If you notice any unusual tingling or a localized rash, contact your healthcare provider immediately, as early antiviral treatment is most effective when started within 72 hours of the first symptoms.





